The +405 GG variant of vascular endothelial growth factor polymorphism is associated with poor prognosis in patients undergoing coronary artery bypass graft surgery

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 11, 2009, Pages 719-725

  Pastuszczak, Maciej ^a   Branicka, Agnieszka ^b   Jakiela, Bogdan ^c   Stȩpień, Ewa ^b   Jaworek, Andrzej K ^c   Wojas Pelc, Anna ^c   Kapelak, Bogusław ^c   Sadowski, Jerzy ^c  

^a Szpital Specjalistyczny Im J Dietla   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cardiovascular surgery; Coronary artery disease; Gene polymorphism; Prognosis; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

AGED; ALLELE; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DISEASE CARRIER; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROGNOSIS; RISK; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 72149086917     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.821     Document Type: Article

References (22)

1. Weigand MA, Hömer C, Bardenheuer HJ, et al. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol. 2004; 18: 455-475. (Pubitemid 38949968)
2. Nathan N, Denizot Y, Cornu E, et al. Cytokine and lipid mediator blood concentrations after coronary artery surgery. Anesth Analg. 1997; 85: 1240-1246. (Pubitemid 28130518)
3. Nathan N, Preux PM, Feiss P, et al. Plasma interleukin-4, interleukin-10, and interleukin-13 concentrations and complications after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2000; 14: 156-160. (Pubitemid 30214865)
4. Denizot Y, Lorgeot V, Cornu E, et al. Plasma leukemia inhibitory factor, interleukin-6 and soluble interleukin-6 receptor levels during cardiopulmonary bypass with extracorporeal circulation. Cytokine. 1998; 10: 303-306. (Pubitemid 28227074)
5. Burton PBJ, Owen VJ, Hafizi S, et al. Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus "beating heart" surgery. Eur Heart J. 2000; 21: 1708-1713.
6. Denizot Y, Guglielmia L, Cornub E. Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications. Cytokine. 2003; 24: 7-12. (Pubitemid 37244155)
7. Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000; 12: 1232-1235.
8. Young HS, Summers AM, Bhushan M, et al. Single-nucleotide polymoprhisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol. 2004; 122: 209-215.
9. Hojo Y, lkeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 2000; 35: 968-973.
10. Heeschen Ch, Dimmeler S, Hamm ChW, et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation. 2003; 107: 524-530. (Pubitemid 36176799)
11. Howell WM, Bateman A, Turner SJ, et al. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun. 2002; 3: 229-232. (Pubitemid 38961136)
12. Stevens A, Soden J, Bernchley PE, et al. Haplotype analysis of the polymporphic human vascular endothelial growth factor gene promoter. Cancer Res. 2003; 63: 812-816. (Pubitemid 36231981)
13. Awata T, lnoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002; 51: 1635-1639.
14. Mehta RH, Honeycutt E, Shaw LK, et al. Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007; 100: 1538-1542. (Pubitemid 350050858)
15. Lee SH, Wolf PL, Escudero R, et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med. 2000; 342: 626-633. (Pubitemid 30118415)
16. Ono K, Matsumori A, Shioi TF, et al. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 1997; 95: 2552-2558. (Pubitemid 27233121)
17. Shweiki D, ltin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiaded angiogenesis. Nature. 1992; 359: 843-845.
18. Valgimigli M, Rigolin GM, Fucili A, et al. CD 34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004; 110: 1209-1212. (Pubitemid 39202334)
19. Walski M, Frontczak-Baniewicz M. [Ultrastructural features of normal and dysfunctional endothelium of the blood vessels). Pol Arch Med Wew. 2007; 117: 46-49. Polish. (Pubitemid 350190335)
20. Van der Meer P, De Boer R, White HL, et al. The VEGF +405 CC Promoter polymorphism is associated with impaired prognosis in patients with chronic heart failure: A MERIT-HF Substudy. J Card Fail. 2005; 11: 279-284. (Pubitemid 40616897)
21. Ferrara N, Houck K, Jakeman KB, et al. The vascular endothelial growth factor family of polypeptides. J Cell Biol. 1991; 47: 211-218.
22. Bryant CE, Appleton I, Mitchell JA. Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells. Life Sci. 1998; 62: 2195-2201. (Pubitemid 28248436)